These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33788863)

  • 1. The long-term impact of the Leprosy Post-Exposure Prophylaxis (LPEP) program on leprosy incidence: A modelling study.
    Blok DJ; Steinmann P; Tiwari A; Barth-Jaeggi T; Arif MA; Banstola NL; Baskota R; Blaney D; Bonenberger M; Budiawan T; Cavaliero A; Gani Z; Greter H; Ignotti E; Kamara DV; Kasang C; Manglani PR; Mieras L; Njako BF; Pakasi T; Saha UR; Saunderson P; Smith WCS; Stäheli R; Suriyarachchi ND; Tin Maung A; Shwe T; van Berkel J; van Brakel WH; Vander Plaetse B; Virmond M; Wijesinghe MSD; Aerts A; Richardus JH
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009279. PubMed ID: 33788863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme.
    Richardus JH; Tiwari A; Barth-Jaeggi T; Arif MA; Banstola NL; Baskota R; Blaney D; Blok DJ; Bonenberger M; Budiawan T; Cavaliero A; Gani Z; Greter H; Ignotti E; Kamara DV; Kasang C; Manglani PR; Mieras L; Njako BF; Pakasi T; Pandey BD; Saunderson P; Singh R; Smith WCS; Stäheli R; Suriyarachchi ND; Tin Maung A; Shwe T; van Berkel J; van Brakel WH; Vander Plaetse B; Virmond M; Wijesinghe MSD; Aerts A; Steinmann P
    Lancet Glob Health; 2021 Jan; 9(1):e81-e90. PubMed ID: 33129378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin.
    Barth-Jaeggi T; Steinmann P; Mieras L; van Brakel W; Richardus JH; Tiwari A; Bratschi M; Cavaliero A; Vander Plaetse B; Mirza F; Aerts A;
    BMJ Open; 2016 Nov; 6(11):e013633. PubMed ID: 27856484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing leprosy post-exposure prophylaxis into the health systems of India, Nepal and Indonesia: a case study.
    Tiwari A; Mieras L; Dhakal K; Arif M; Dandel S; Richardus JH;
    BMC Health Serv Res; 2017 Sep; 17(1):684. PubMed ID: 28962564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis.
    Steinmann P; Cavaliero A; Aerts A; Anand S; Arif M; Ay SS; Aye TM; Barth-Jaeggi T; Banstola NL; Bhandari CM; Blaney D; Bonenberger M; VAN Brakel W; Cross H; DAS VK; Fahrudda A; Fernando N; Gani Z; Greter H; Ignotti E; Kamara D; Kasang C; Kömm B; Kumar A; Lay S; Mieras L; Mirza F; Mutayoba B; Njako B; Pakasi T; Saunderson P; Shengelia B; Smith CS; Stäheli R; Suriyarachchi N; Shwe T; Tiwari A; Wijesinghe MSD; VAN Berkel J; Vander Plaetse B; Virmond M; Richardus JH
    Lepr Rev; 2018 2nd Quarter; 89(2):102-116. PubMed ID: 37180343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of contact tracing and prevention strategies in the interruption of leprosy transmission.
    Smith WC; Aerts A
    Lepr Rev; 2014 Mar; 85(1):2-17. PubMed ID: 24974438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.
    Ortuno-Gutierrez N; Younoussa A; Randrianantoandro A; Braet S; Cauchoix B; Ramboarina S; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Richardus JH; de Jong BC; Hasker E
    BMC Infect Dis; 2019 Dec; 19(1):1033. PubMed ID: 31805862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatio-temporal analysis of leprosy risks in a municipality in the state of Mato Grosso-Brazilian Amazon: results from the leprosy post-exposure prophylaxis program in Brazil.
    Machado LMG; Dos Santos ES; Cavaliero A; Steinmann P; Ignotti E
    Infect Dis Poverty; 2022 Feb; 11(1):21. PubMed ID: 35193684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leprosy post-exposure prophylaxis in the Indian health system: A cost-effectiveness analysis.
    Tiwari A; Blok DJ; Arif M; Richardus JH
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008521. PubMed ID: 32750059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Number of people requiring post-exposure prophylaxis to end leprosy: A modeling study.
    Taal AT; Blok DJ; van Brakel WH; de Vlas SJ; Richardus JH
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009146. PubMed ID: 33630836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the impact of household contact and mass chemoprophylaxis on future new leprosy cases in South Tarawa, Kiribati: A modelling study.
    Gilkison C; Chambers S; Blok DJ; Richardus JH; Timeon E; Rimon E; Priest P
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007646. PubMed ID: 31539374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PEP++ study protocol: a cluster-randomised controlled trial on the effectiveness of an enhanced regimen of post-exposure prophylaxis for close contacts of persons affected by leprosy to prevent disease transmission.
    Hinders DC; Taal AT; Lisam S; da Rocha AM; Banstola NL; Bhandari P; Saha A; Kishore J; Fernandes VO; Chowdhury AS; van 't Noordende AT; Mieras L; Richardus JH; van Brakel WH
    BMC Infect Dis; 2024 Feb; 24(1):226. PubMed ID: 38378497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia.
    Tiwari A; Dandel S; Djupuri R; Mieras L; Richardus JH
    BMC Infect Dis; 2018 Jul; 18(1):324. PubMed ID: 29996781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.
    Mieras L; Anthony R; van Brakel W; Bratschi MW; van den Broek J; Cambau E; Cavaliero A; Kasang C; Perera G; Reichman L; Richardus JH; Saunderson P; Steinmann P; Yew WW
    Infect Dis Poverty; 2016 Jun; 5(1):46. PubMed ID: 27268059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing leprosy with retrospective active case finding combined with single-dose rifampicin for contacts in a low endemic setting: results of the Leprosy Post-Exposure Prophylaxis program in Cambodia.
    Cavaliero A; Ay SS; Aerts A; Lay S; So V; Robijn J; Steinmann P
    Acta Trop; 2021 Dec; 224():106138. PubMed ID: 34562427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of leprosy using rifampicin as chemoprophylaxis.
    Bakker MI; Hatta M; Kwenang A; Van Benthem BH; Van Beers SM; Klatser PR; Oskam L
    Am J Trop Med Hyg; 2005 Apr; 72(4):443-8. PubMed ID: 15827283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist's dilemma.
    Parajuli N; Poudyal Y
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009039. PubMed ID: 33830989
    [No Abstract]   [Full Text] [Related]  

  • 18. Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.
    Younoussa A; Samidine SN; Bergeman AT; Piubello A; Attoumani N; Grillone SH; Braet SM; Tsoumanis A; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Snijders R; Corstjens P; Ortuno-Gutierrez N; Hoof C; Geluk A; de Jong BC; Hasker E
    BMC Infect Dis; 2023 May; 23(1):310. PubMed ID: 37161571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial.
    Hasker E; Assoumani Y; Randrianantoandro A; Ramboarina S; Braet SM; Cauchoix B; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Attoumani N; Grillone SH; Ronse M; Peeters Grietens K; Rakoto-Andrianarivelo M; Harinjatovo H; Supply P; Snijders R; Hoof C; Tsoumanis A; Suffys P; Rasamoelina T; Corstjens P; Ortuno-Gutierrez N; Geluk A; Cambau E; de Jong BC
    Lancet Glob Health; 2024 Jun; 12(6):e1017-e1026. PubMed ID: 38762282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprosy New Case Detection Trends and the Future Effect of Preventive Interventions in Pará State, Brazil: A Modelling Study.
    de Matos HJ; Blok DJ; de Vlas SJ; Richardus JH
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004507. PubMed ID: 26938738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.